KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Net Income - Minority (2016 - 2018)

Vertex Pharmaceuticals (VRTX) has 8 years of Net Income - Minority data on record, last reported at -$28.4 million in Q3 2018.

  • For Q3 2018, Net Income - Minority fell 133.13% year-over-year to -$28.4 million; the TTM value through Sep 2018 reached -$28.4 million, down 133.13%, while the annual FY2017 figure was -$13.7 million, 92.44% up from the prior year.
  • Net Income - Minority reached -$28.4 million in Q3 2018 per VRTX's latest filing, up from -$29.8 million in the prior quarter.
  • Across five years, Net Income - Minority topped out at -$12.2 million in Q3 2017 and bottomed at -$187.5 million in Q2 2016.
  • Average Net Income - Minority over 5 years is -$106.1 million, with a median of -$153.5 million recorded in 2015.
  • Peak YoY movement for Net Income - Minority: tumbled 654.87% in 2016, then skyrocketed 93.49% in 2017.
  • A 5-year view of Net Income - Minority shows it stood at -$21.2 million in 2014, then tumbled by 625.6% to -$153.7 million in 2015, then fell by 18.19% to -$181.6 million in 2016, then soared by 92.44% to -$13.7 million in 2017, then tumbled by 106.64% to -$28.4 million in 2018.
  • Per Business Quant database, its latest 3 readings for Net Income - Minority were -$28.4 million in Q3 2018, -$29.8 million in Q1 2018, and -$13.7 million in Q4 2017.